McKesson Corporation Extends Pharmaceutical Distribution Agreement With CVS Health
September 29 2022 - 4:10PM
Business Wire
Announces second-quarter fiscal 2023 earnings
release date
McKesson Corporation (NYSE: MCK) today announced that it has
signed an agreement in principle to extend its partnership with CVS
Health to distribute pharmaceuticals to mail order and specialty
pharmacies, retail pharmacies and distribution centers through June
2027.
“We are pleased to continue our long-standing relationship with
CVS Health and value the shared commitment of improving health
outcomes for all patients,” said Brian Tyler, chief executive
officer, McKesson. “We are privileged to extend our partnership of
more than 20 years to continue developing value propositions for
patients utilizing our diverse set of differentiated assets and
capabilities.”
Additionally, McKesson will release its second-quarter fiscal
2023 financial results after market close on Tuesday, November 1,
2022. The company will host a live webcast of the earnings
conference call for investors at 4:30 PM Eastern Time to review its
financial results.
The live webcast will be available on McKesson’s Investor
Relations website at http://investor.mckesson.com, along with the
company’s earnings press release, financial tables and slide
presentation.
About McKesson Corporation
McKesson Corporation is a diversified healthcare services leader
dedicated to advancing health outcomes for patients everywhere. Our
teams partner with biopharma companies, care providers, pharmacies,
manufacturers, governments, and others to deliver insights,
products and services to help make quality care more accessible and
affordable. Learn more about how McKesson is impacting virtually
every aspect of healthcare at McKesson.com and read Our
Stories.
CAUTIONARY STATEMENTS
This news release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section
21E of the Securities Exchange Act of 1934 related to an agreement
in principle. Readers should not place undue reliance on
forward-looking statements, which speak only as of the date they
are first made. Except to the extent required by law, we undertake
no obligation to update or revise our forward-looking statements.
Forward-looking statements involve risks and uncertainties that
could cause actual results to differ materially from those
projected, anticipated, or implied. Although it is not possible to
predict or identify all such risks and uncertainties, we encourage
investors to read the risk factors described in our most recent
annual and periodic report filed with the Securities and Exchange
Commission. Risk factors related to the anticipated definitive
contract include, but are not limited to: there could be delays in
signing a definitive contract due to protracted negotiations; the
parties might fail to sign a definitive contract for the term
extension; and we might not realize all of the financial and
operational benefits that we expect from a contract renewal.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220929005855/en/
Rachel Rodriguez, 469-260-0556 (Investors)
Rachel.Rodriguez@McKesson.com David Matthews, 214-952-0833 (Media)
David.Matthews@McKesson.com
McKesson (NYSE:MCK)
Historical Stock Chart
From Jun 2024 to Jul 2024
McKesson (NYSE:MCK)
Historical Stock Chart
From Jul 2023 to Jul 2024